Accepted at 5:28 p.m. Sep, 24, 2024 by DillingerMed
Author: mohannadkh10
Related Note: 1485037207685 1
Rationale for change

I dont like the fact that venlafaxine has special attention

Neither Amboss nor UW focuses on it specifically

- Edit: I just checked FA which used to say venlafaxine specifically and I can confirm that FA24 says SNRI now instead of venlafaxine

Source: AMBOSS - https://next.amboss.com/us/article/kP0mUT?q=social%20anxiety%20disorder#S2cySb0

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Other::Only_Step_1&2_Overlap #AK_Step1_v12::#Bootcamp::Psychiatry::04_Anxiety_Trauma_and_Stress_Disorders::02_Phobias #AK_Step2_v12::Original_decks::Dorian::fam::ome::psych::pharm #AK_Step2_v12::!Shelf::FM::no_dupes #PANCE::EOR::PEDS #AK_Step1_v12::#UWorld::COMLEX::26343 #AK_Step2_v12::#Resources_by_rotation::FM::ome::psych::pharm #PANCE::EOR::PSYCH #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::02_Anxiolytic_and_Hypnotic_Drugs #AK_Step1_v12::#Physeo::09_Pharm::13_Psychiatric::20_SNRIs #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step2_v12::#UWorld::Step::3839 #AK_Step1_v12::#SketchyPharm::06_Neuro_&_Psych::02_Antidepressants_&_Anxiolytics::01_SSRIs,_SNRIs,_Cyproheptadine #AK_Step1_v12::#Pixorize::03_Pharmacology::17_Psych_Pharm::04_SSRIs #AK_Step1_v12::#UWorld::Step::15481 #AK_Step1_v12::#FirstAid::13_Psych::03_Pharm::07_Selective_serotonin_reuptake_inhibitors #PANCE::BEHAVIORAL::anxiety_disorders #AK_Step1_v12::#FirstAid::13_Psych::03_Pharm::08_Serotonin-norepinephrine_reuptake_inhibitors #AK_Step1_v12::#Pixorize::^Missing_image #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::^Systems::Neuro::Pharmacology #AK_Step1_v12::#Physeo::09_Pharm::13_Psychiatric::19_SSRIs #AK_Step2_v12::!Shelf::Psych::no_dupes #AK_Step2_v12::#NBME::Form14::Section_1 #AK_Step2_v12::#UWorld::COMLEX::107297 #AK_Step2_v12::#AMBOSS::fH0kph #AK_Step2_v12::#Bootcamp::Psychiatry::01_Diagnosis_and_Management::01_Mood_Disorders::05_SSRIs_and_SNRIs #AK_Step1_v12::#OME::Clinical::Pediatrics/Psychiatry #AK_Step2_v12::#Resources_by_rotation::Psych::fapsych::pharm #AK_Step2_v12::#SketchyPsych::02_Anxiety_Disorders::02_Panic_Disorders::02_Phobias #AK_Step1_v12::#Pixorize::03_Pharmacology::17_Psych_Pharm::New::10_SSRIs #AK_Step1_v12::#FirstAid::13_Psych::03_Pharm::06_Antidepressants::*Preferred_Medications_For_Selected_Psychiatric_Conditions #AK_Step2_v12::#FirstAid::13_Psych::04_Anxiety_Disorders::03_Phobias_(Social_and_Specific) #AK_Step1_v12::#Bootcamp::Psychiatry::09_Pharmacology::01_SSRIs #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::#AMBOSS #AK_Step2_v12::Original_decks::Dorian::psych::fapsych::pharm